Navigation Links
Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate
Date:5/19/2010

ivity, respectively. Soligenix is also continuing to actively build intellectual property around oral BDP in other inflammatory conditions and has obtained orphan drug designation for the treatment of pediatric Crohn's Disease.

About Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder that affects the large intestine (colon).  IBS commonly causes cramping, abdominal pain, bloating gas, diarrhea and constipation and is generally very disruptive to daily living activities.  It is usually treated with anti-diarrheal agents such as loperamide, anticholinergic agents, and prokinetic agents.  IBS has been called spastic colon, functional bowel disease, and mucous colitis. IBS affects up to 55 million Americans, mostly women, and its causes are unknown.

IBS represents a therapeutic challenge to both clinicians and developers of pharmaceuticals. The uncertainty and variety of causes, as well as the variable nature of symptomatic expression greatly complicates the task of treating this disorder.  In IBS, the movement of the digestive tract does not work as it should, but there is no sign of changes in the intestines, such as inflammation or tumors. It is thought that IBS symptoms are related to problems with the signals sent between the brain and the intestines which in turn cause problems with the way the muscles of the intestines move.

About oral BDP

Beclomethasone dipropionate (BDP) is a highly potent, topically active corticosteroid that has a local effect on inflamed tissue. BDP has been marketed in the US and worldwide since the early 1970s as the active pharmaceutical ingredient in a nasal spray and in a metered-dose inhaler for the treatment of patients with allergic rhinitis and asthma. BDP is the active ingredient in
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX
2. Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors
3. Soligenix to Present at 8th Annual BIO Investor Forum
4. Soligenix to Present at 12th Annual BIO CEO & Investor Conference
5. Soligenix Reports Third Quarter 2009 Financial Results
6. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
7. Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial
8. Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... May 16, 2013 Scientists at the Center ... , and the California -based ... a novel therapy for reversing memory decline in mice ... find significant cognitive improvement in advanced stage AD mice. ... for reversing cognitive decline for advanced stage AD mice, ...
(Date:5/16/2013)... 16, 2013 Reportlinker.com announces ... is available in its catalogue: ... Analysis: Therapeutic Proteins – Biosimilars, Biobetters ...   Product ... The new Competitive Intelligence Report Therapeutic ...
(Date:5/16/2013)... ON (PRWEB) May 16, 2013 DNA Genotek, ... announced ‘Spit for Africa’, a sponsorship program in conjunction with ... is designed to improve access and reduce the cost of ... projects such as the Human Heredity and Health in Africa ... the AfSHG. , The aim of the AfSHG ...
(Date:5/16/2013)... York, NY (PRWEB) May 16, 2013 ... Insights: Market Access Success for Companion Diagnostic–Drug Pairings ... key issues that biopharmaceutical manufacturers should understand when ... is gaining traction, particularly in oncology, with two ... and Zelboraf for BRAF-mutation positive melanoma. Payors are ...
Breaking Biology Technology:Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3Market Access Expert Firm, PRMA Consulting, Launches Companion Diagnostics Handbook 2
... Micromet, Inc. (Nasdaq: MITI ), a ... treatment of cancer, inflammation and autoimmune diseases, today ... Journal of Immunotherapy (1) demonstrating the potent anti-tumor ... antigen (CEA) and to CD3 on T cells. ...
... Scientists have designed tiny new sensor structures that could ... and explosives, or in highly sensitive medical sensors, according ... Letters . , The new ,nanosensors, which are ... and US research groups, could be tailor-made to instantly ...
... Impact Systems, video is chosen as a finalist in the International ... ... Greenville, DE (PRWEB) April 7, 2009 -- Impact Systems ... (ECM) software tools and services, today announced their Compliance-in-a-Box video has ...
Cached Biology Technology:Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 2Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 3Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 4New security and medical sensor devices made possible by metallic nanostructures 2Impact Systems' Compliance-in-a-Box™ Video is Announced as "Be the Buzz of Bio" Contest Finalist 2Impact Systems' Compliance-in-a-Box™ Video is Announced as "Be the Buzz of Bio" Contest Finalist 3
(Date:5/16/2013)... use of genome-wide analysis (GWA), where the entirety of ... genomic mutations or variants which can cause health problems ... However, it can also pose major ethical problems if ... of Human Genetics (ESHG) published on line today (16 ... Genetics ., Many services based on whole genome and ...
(Date:5/16/2013)... and the manager of San Diego Zoo Global,s Central ... award. The Whitley award is an international competition ... celebrates the extraordinary achievements of some of the world,s ... selected for the award due to his efforts to ... wildlife inhabitants., HRH The Princess Royal, the charity,s patron, ...
(Date:5/16/2013)... NEW YORK , May 16, 2013 ... market research report is available in its ... Market Forecast & Opportunities, 2018 ... data protection and old security practises such ... driven the growth of biometric technologies in ...
Breaking Biology News(10 mins):European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7
... with basic scientists from the University of California, Irvine ... for normal development of the reproductive, olfactory and circadian ... report to appear in the Proceedings of the National ... gene called PROK2 (prokineticin 2) in human siblings with ...
... mind,s growth -- but it does not have to stop ... of adult monkeys. A team of neuroscientists has ... at which new neural cells form in the hippocampus region ... associated with both learning and memory. While other research groups ...
... service, developed in the framework of an ESA-supported project, ... across Europe in order to ensure the more efficient ... European Union (EU) must be registered with the national ... (EPPO), which requires efficiency data derived from field trials. ...
Cached Biology News:Study identifies pathway required for normal reproductive development 2Study identifies pathway required for normal reproductive development 3Brain cell growth diminishes long before old age strikes, animal study shows 2
...
IHC detection kit for BrdU in cells and tissues...
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Request Info...
Biology Products: